O CD is a severe and chronic anxiety disorder characterized by the repeated occurrence of obsessions and (or) compulsions to the extent that it causes marked distress or impairment. 1 In severe cases, which may account for up to 20% of people with the diagnosis, 2 a person can spend the entire day consumed by their obsessions and compulsions, thus resulting in profound disability. The quality of life of people with OCD has been examined surprisingly little in comparison with other anxiety disorders, 3,4 but accumulating evidence suggests that the adverse impact of OCD on quality of life is at least comparable with other anxiety disorders 5 and is greater than other disorders, including schizophrenia. 6 For W La Revue canadienne de psychiatrie, vol 54, no 7, juillet 2009 460 Objective: To compare the quality of life of patients with obsessive-compulsive disorder (OCD) with and without depression comorbidity.
instance, a recent meta-analysis comparing the quality of life in different anxiety disorders, including OCD, demonstrated that anxiety disorders exact a large cost in terms of reduced quality of life relative to control subjects. 6 When different domains of quality of life were considered separately, a primary diagnosis of OCD was found to lead to significant and large effect size differences on social functioning (d = 0.98), occupational functioning (d = 0.96), mental health (d = 0.85), physical health (d = 0.75), and home and family functioning (d = 0.71), compared with control subjects.
In recent attempts to delineate whether particular features of OCD are more costly in terms of quality of life, the severity of obsessions has been found to be more predictive of poor quality of life than the severity of compulsions. 7, 8 However, even more predictive than the severity of OCD symptoms has been the finding that secondary depression symptoms are the greatest predictor of poor quality of life in patients with primary OCD. [7] [8] [9] For example, our group previously found that dimensional ratings of depressed mood (BDI-II) was the single greatest predictor of poor quality of life, accounting for more than 50% of the variance in quality of life ratings in patients with primary OCD. 8 Further examination of the role of depression in OCD is an extremely important issue given that more than any other anxiety disorder, OCD is complicated by depression comorbidity, [10] [11] [12] [13] [14] [15] typically identified as the secondary disorder. 13, 16 Major depression comorbidity in OCD is associated with earlier onset and greater chronicity in the course. 17, 18 Comorbid depression in OCD also appears to increase the severity and risk associated with the disorder as comorbidity has been found to be associated with more thoughts of death and suicide 17 as well as actual suicide attempts and hospitalizations. 19 Although people with comorbid depression are often excluded from randomized controlled trials, a small extant body of literature indicates that people with comorbid depression have comparatively poorer treatment outcomes. [20] [21] [22] In summary, previous research has documented the important decrements in the quality of life of patients with OCD. Epidemiologic and clinical research studies have also demonstrated the common frequency of comorbid major depression in the clinical course of OCD. While studies have demonstrated the impact of comorbid depression on the course of OCD and treatment outcome, little research has examined the impact of depression comorbidity on patients' quality of life. In a previous study, we demonstrated that dimensionally rated depression scores were the greatest predictor of poor quality of life in OCD. However, elevated BDI-II scores can also represent a proxy for greater psychiatric morbidity and so in this study, we aimed to re-examine the impact of clinically diagnosed depression on the quality of life of patients with primary OCD while controlling for the impact of other psychiatric comorbidities and general distress ratings in carefully matched patient samples. Patients with OCD often have more than one comorbid condition at the time of clinical assessment. 23 Controlling for the presence of dimensionally rated symptom severity and other comorbid psychiatric disorders would provide a rigorous test of the specific impact of comorbid major depression on the quality of life in OCD.
Following expert consensus on the operationalization and measurement of quality of life, 4 we sought to measure a person's subjective perception of his or her quality of life, including multiple dimensions of quality of life rather than one omnibus rating. We also examined quality of life with a generic measure rather than a problem-or disorder-specific measure. In particular, our study sought to address whether there are global and (or) domain specific differences in quality of life between patients with and without comorbid depression. Our study also sought to determine whether any differences on quality of life ratings observed between the 2 patient groups could be better accounted for by the presence of more severe obsessive-compulsive symptoms or psychiatric morbidity.
Methods
Our study received ethics board approval from the Centre for Addiction and Mental Health.
Clinical Sample
Treatment-seeking outpatients (n = 56) who were continuous referrals to a university-affiliated anxiety disorders clinic were recruited for this study. All participants met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for OCD (n = 28) or comorbid OCD and MDD (n = 28) based on the SCID, Patient Edition, version 2.0. To be eligible for inclusion, participants had to be aged between 18 and 65 years and have a primary diagnosis of OCD with or without comorbid depression. Other comorbid conditions included additional anxiety disorders (panic disorder, social phobia, specific phobia, posttraumatic stress disorder, generalized anxiety disorder), tic disorder, trichotillomania, and impulse control disorder not otherwise specified. Social phobia was the most common comorbid condition, endorsed by 14.3% of participants in the OCD-MDD group, and by 10.7% of participants in the OCD group. Patients were excluded if they had a concurrent diagnosis of schizophrenia, bipolar disorder, or current substance use disorder. All participants were on stable medications, as defined by no change in medication type or dose for 4 weeks before assessment, and were able to provide informed consent. The SCID interviews were administered by research staff who had received formal training in the administration and scoring of the interview protocol, and who had completed a rigorous interrater reliability training program. Raters observed and scored 10 SCID, Patient Edition tapes and achieved 100% diagnostic agreement for the primary and secondary diagnoses prior to the start of the study. All assessors attended weekly clinical case conference meetings to discuss issues pertaining to the delivery and scoring of the SCID interviews.
Clinical Measures Quality of Life Enjoyment and Satisfaction Questionnaire.
The QLES 24 is one of the most commonly employed measures to assess quality of life in anxiety disorders. 4 The QLES is a reliable and valid multidimensional self-report measure of quality of life consisting of 93 items that are grouped into 8 subscales: physical health (for example, "felt rested?," "felt good physically?"), subjective feelings (for example, "felt happy or cheerful?," "felt satisfied with your life?"), work (for example, "enjoyed your work?," "worked well?"), household duties (for example, "had a feeling of accomplishment with regard to household activities?," "solved household problems or dealt with them without undue stress?"), schoolwork (for example, "enjoyed the course or class work?," "dealt with course or class work without undue stress?"), leisure time activities (for example, "enjoyed the leisure activities?," "leisure activity sustain your interest?"), social relations (for example, "looked forward to getting together with friends or relatives?," "made social plans with friends or relatives for future activities?"), and general activities (for example, "ability to function in daily life?," "overall sense of well-being?").
Responses are rated on a 5-point Likert scale, with higher scores indicating better quality of life in that domain. Certain domains (that is, work, household duties, and schoolwork) are to be completed only if the respondent is actively involved in the activities that comprise that domain. Reliability estimates have been shown to be good for each of the 8 subscales, ranging from 0.80 to 0.95, and good test-retest reliability has been established. In our study, the alpha coefficients were found to be acceptable for each of the 8 subscales: physical health (a = 0.90), subjective feelings (a = 0.91), work (a = 0.99), household duties (a = 0.94), schoolwork (a = 0.97), leisure time activities (a = 0.89), social relations (a = 0.88), and general activities (a = 0.86).
Beck Depression Inventory. 25 The BDI-II is a 21-item (4-point scale) self-report instrument designed to assess the severity of depressive symptoms over the preceding week. The BDI-II has been shown to be a reliable and well-validated measure of depressive symptomatology. 25, 26 Yale-Brown Obsessive Compulsive Scale. 27 The Y-BOCS is a standardized rating scale measuring 10 items pertaining to obsessions and compulsions on a 5-point Likert scale ranging from 0 (no symptoms) to 4 (severe symptoms). The clinicianadministered version has been shown to possess high internal consistency and validity. 27, 28 Prior to conducting the study, the assessment team completed a rigorous training session in the administration and scoring of the Y-BOCS. As part of the training, all assessors viewed and rated 15 clinical interviews. The level of internal agreement on rated Y-BOCS items was 0.987, demonstrating excellent standardization.
Statistical Methods
Data were analyzed using SPSS version 14.0 (SPSS Inc, Chicago, IL). Chi-square analyses were conducted, in the case of categorical variables, and analyses of variance were conducted, in the case of continuous variables, to compare the groups on demographic and clinical variables. While one omnibus multivariate analysis of variance would be preferred to analyze group differences in quality of life, given the likely multicolinearity amongst the quality of life subscales, this was not possible because not all participants completed the ratings for each of the 8 quality of life subscales (for example, only 15 participants were in school, and only 37 participants were working). Alternatively, 8 separate analyses of variance were completed with the dependent variable being one of the 8 QLES subscales and the between-group variable being diagnostic group (OCD, compared with OCD-MDD). These analyses were repeated using analyses of covariance controlling for Y-BOCS scores and number of comorbid diagnoses. Given the large number of analyses and the increased potential for a type 1 error, a Bonferonni correction was applied for the determination of significance in the univariate analyses (a = 0.05/24 tests = 0.002).
Results

Demographics
Patient groups were matched by age, sex, and antidepressant medication use, and were found to be equivalent on all baseline demographic variables (Table 1) . Group means for the Y-BOCS subscale and total scores, BDI-II total scores, and number of additional comorbid disorders, as well as F values and effect sizes are reported in Table 2 . Patients in the comorbid group reported greater obsession and compulsion symptom severity, depression severity, and a greater number of comorbid Axis I diagnoses beyond depression comorbidity.
Quality of Life Domains in OCD With and Without Depression Comorbidity
Group means for the QLES, as well as F values and effect sizes, are reported in Table 3 . The comorbid group scored significantly lower on QLES subjective feelings, social relations, and general activities. No differences were observed between the 2 groups on QLES physical health, work, household duties, schoolwork, or leisure time.
Quality of Life Domains in OCD With and Without Depression Comorbidity Controlling for Number of Comorbid Diagnoses and OCD Severity
To examine whether group differences on quality of life ratings could be better accounted for by psychiatric morbidity or the presence of more severe obsessive-compulsive symptoms, the analysis above was repeated controlling for number of additional comorbid diagnoses and Y-BOCS scores.
The number of additional comorbid diagnoses was not significantly associated with any of the quality of life domains, and entering the number of additional diagnoses as a covariate did not affect the pattern of results. The comorbid group continued to score significantly lower than the OCD group on QLES subjective feelings (F = 30.61, df = 1,53, P < 0.001), social relations (F = 17.02, df = 1,53, P < 0.001), and general activities subscales (F = 15.92, df = 1,53, P < 0.001).
Entering OCD obsession and compulsion severity as covariates did impact the results somewhat. While the comorbid group continued to score lower than the OCD group on QLES subjective feelings (F = 22.20, df = 1,53, P < 0.001), and social relations (F = 10.30, df = 1,52, P = 0.002), the comorbid and OCD groups no longer differed significantly from one another on the QLES general activities subscale when controlling for OCD severity (F = 7.15, df = 1,53, P = 0.01). Although OCD severity was not significantly associated with QLES general activities scores following the Bonferroni correction, the QLES general activities subscale was impacted to a greater extent by obsession severity (F = 6.48, df = 1,52, P = 0.01), than compulsion severity (F = 0.001, df = 1,52, P = 0.99).
Discussion
Previous research has demonstrated that core aspects of quality of life are significantly affected in OCD. 4, 6, 29 Our study aimed to examine the impact of depression comorbidity on patients' perceived quality of life. As observed, the presence of depression comorbidity was found to significantly impact on subjective feelings, social relations, and a composite measure of general activities. The effect size differences were moderate to very large (ranging from 0.55 to 1.72), pointing to the statistical and clinical meaningfulness of the observed between-group differences.
As other domains of quality of life, such as physical health, household duties, occupational functioning, leisure pursuits, and academic study, were not found to differ between the clinical groups, the findings point to the specific effects of comorbid depression on subjective feelings, social functioning, and overall well-being and ability to function with the disorder. The QLES subjective feelings subscale asks respondents to rate how much of the time they feel: happy, content, satisfied with life, able to think clearly and make decisions, and interested in performing activities of daily living. The QLES social relations subscale asks respondents to rate the frequency of their social plans and the enjoyment they derive from spending time with others. Given that MDD is associated with depressed mood, loss of interest or pleasure, social withdrawal, and impaired concentration, it is perhaps not surprising that the comorbid OCD-MDD group scored lower on these domains, compared with the OCD group.
The comorbid OCD-MDD group also scored lower on the composite measure of general activities, and a post hoc item analysis of this subscale indicated that they rated their overall mood, social and family relations, sense of well-being, and life satisfaction lower than the OCD group. The particular mechanisms by which the presence of comorbid depression influences quality of life remain to be examined. One possibility is that the depressed state itself confers additional burdens that severely limit a person's quality of life. A second, and not mutually exclusive possibility, is that patients with comorbid depression disqualify positive aspects of their environment which functions to enhance the perceived decrements in quality of life.
The finding that the groups no longer differed when OCD, specifically obsessional severity, was entered as a covariate suggests that the greater severity of obsessive thinking in the comorbid group uniquely contributed to lower subjective well-being and life satisfaction in this group. This finding is consistent with previous research reporting that severity of depression and obsessions, but not compulsions, predicts illness intrusiveness. 8 In the absence of experimental studies examining the mechanisms by which the presence of comorbid depression exacerbates the frequency and severity of clinical obsessions, our clinical experience suggests at least 2 possible routes that require further examination. One possibility is that cognitive features germane to depression, such as cognitive rumination, 30 increase the likelihood that the person will become stuck mentally rehearsing the obsessional content. A second possibility is that the presence of a depressed state may increase both the sensitivity to, and the resulting distress experienced around, the arrival of an unwanted intrusion, either through a taxing of coping resources or through a reduction in the perceived resources to cope with unwanted intrusions.
The efficacy of current first-line pharmacological, 31 psychological, 32 and combined treatments 33 for OCD has been demonstrated primarily in patients without comorbid major depression. Although psychological treatments for OCD such as cognitive-behavioural therapy and exposure and response prevention have been shown to improve both OCD symptom severity and quality of life, 34 this effect is greater for treatment responders, 35 and people with comorbid depression have been shown to demonstrate a poorer response to treatment. 20, 21 Indeed, a study examining whether varying pretreatment depression levels predicted treatment response to intensive exposure and response prevention reported that none of the severely depressed patients were deemed treatment responders in terms of clinically significant change. 20 In response to pharmacotherapy in OCD, dimensionally rated depressive severity scores have been found to predict poor treatment response to selective serotonin agents such as fluoxetine. 31 A review paper of pharmacological treatments for OCD reported that 40% to 60% of patients with OCD do not respond to adequate treatment trials with clomipramine or selective serotonin reuptake inhibitors, and that comorbid psychiatric disorders including major depression pose a particular challenge in pharmacological treatment. 36 A recent meta-analysis concluded that antipsychotic augmentation is efficacious for treatment-refractory OCD, although very few studies reported significant improvement in depression severity following augmentation strategies. 37 The results of our study suggest that treatments specifically targeting obsessions may have a greater impact on overall well-being and life satisfaction, and that active treatment of secondary major depression in the context of OCD could improve the quality of life above and beyond specific reductions in OCD symptoms. It has been suggested that the efficacy of traditional exposure and response prevention may be enhanced if cognitive therapy is introduced at the initial stage in treatment to reduce depressive symptoms and enhance motivation and treatment compliance, 38 and there is now preliminary evidence supporting this claim. 39 There is a clear need for greater examination of first-line pharmacological and psychological treatments for OCD that is complicated by significant depression comorbidity, and for the inclusion of generic quality of life measures in treatment outcome studies. There also appears to be a need for the exploration of alternative treatments and (or) alternative delivery systems of care (for example, cognitive therapy as a prelude to traditional exposure and response prevention, augmentation therapy, and stepped care approaches, including more intensive treatments such as day treatment or residential treatment programs) for patients presenting with comorbid depression, to reduce severe and chronic symptoms and improve quality of life.
Our study has numerous methodological strengths, including the use of a reliable and valid multidimensional measure of quality of life, clearly defined and well-diagnosed patient groups matched by age, sex, and antidepressant medication use, validated clinical assessment measures of obsessions and compulsions, and the employment of a statistical approach that controlled for potentially confounding clinical variables. However, the results from our study should be viewed as preliminary, given its small sample size and cross-sectional design. Although a power analysis determined that the overall sample size (n = 56) was sufficient given the large effect size differences, not all participants were performing household activities (n = 50), working (n = 37), or attending classes (n = 15), thus these results may be limited by small sample size. A longitudinal study would provide the context for the assessment of the directionality of effects and stability of the patterns over time. Finally, future research would ideally aim to examine the ability of pharmacological and psychological treatments to improve the quality of life in OCD in the presence of major depression comorbidity.
Conclusions
Patients with comorbid OCD and MDD report significantly greater decrements in their subjective feelings, social Méthode : Des patients externes en traitement (n = 56) souffrant du TOC (n = 28) ou du TOC comorbide et du trouble dépressif majeur (TDM) (n = 28) jumelés selon l'âge, le sexe, et l'utilisation d'antidépresseurs, ont complété une mesure multidimensionnelle de la qualité de vie.
Résultats : Les patients souffrant de TOC comorbide et de TDM déclaraient des diminutions significativement plus importantes de leurs sentiments subjectifs, de leurs relations sociales, et d'une mesure composée des activités générales (par exemple, le bien-être général, et la satisfaction de vivre) en comparaison des patients souffrant de TOC sans TDM. Ces différences n'étaient pas attribuables à la présence d'autres troubles comorbides de l'axe I.
Conclusions:
Les traitements abordant la dépression comorbide dans le contexte du TOC primaire sont nécessaires pour améliorer la qualité de vie de la population souffrant de TOC gravement affectée.
